Advanced search
Publication Cover
Current Medical Research and Opinion Volume 30, 2014 - Issue 11
Submit an article Journal homepage
1,573
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

Comparative effectiveness of second-line targeted therapies for metastatic renal cell carcinoma: synthesis of findings from two multi-practice chart reviews in the United States

James E. SignorovitchAnalysis Group Inc. Boston, MAUSACorrespondence[email protected]
,
Nicholas J. VogelzangUS Oncology Research, Comprehensive Cancer Centers of Nevada Las Vegas, NVUSA
,
Sumanta K. PalCity of Hope Comprehensive Cancer Center Duarte, CAUSA
,
Peggy L. LinAnalysis Group Inc. Boston, MAUSA
,
Daniel J. GeorgeGU Oncology, Duke Cancer Institute Durham, NCUSA
,
Michael K. WongUniversity of Southern California Norris Comprehensive Cancer Center Los Angeles, CAUSA
,
Zhimei LiuNovartis Pharmaceuticals Corporation East Hanover, NJUSA
,
Xufang WangNovartis Pharmaceuticals Corporation East Hanover, NJUSA
,
Ken CulverNovartis Pharmaceuticals Corporation East Hanover, NJUSA
,
Jeffrey A. ScottCardinal Health Grand Prairie, TXUSA
&
Eric JonaschMD Anderson Cancer Center Houston, TXUSA
 show all
Pages 2343-2353 | Accepted 24 Jul 2014, Published online: 27 Aug 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

José Luis González-Larriba, Pablo Maroto, Ignacio Durán, Julio Lambea, Luis Flores, Daniel Castellano & the Changing Group. (2017) The role of mTOR inhibition as second-line therapy in metastatic renal carcinoma: clinical evidence and current challenges. Expert Review of Anticancer Therapy 17:3, pages 217-226.
Read now
Nicholas J. Vogelzang, Sumanta K. Pal, James E. Signorovitch, William M. Reichmann, Nanxin Li, Chelsey Yang, Zhimei Liu, Jose Ricardo Perez & Eric Jonasch. (2016) Comparative effectiveness of everolimus and axitinib as second targeted therapies for metastatic renal cell carcinoma in the US: a retrospective chart review. Current Medical Research and Opinion 32:4, pages 741-747.
Read now
Michael K Wong, Eric Jonasch, Sumanta K Pal, James E Signorovitch, Peggy L Lin, Xufang Wang, Zhimei Liu, Ken Culver, Jeffrey A Scott, Daniel J George & Nicholas J Vogelzang. (2015) Prognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United States. Expert Opinion on Pharmacotherapy 16:6, pages 805-819.
Read now
Eric Jonasch, James E. Signorovitch, Peggy L. Lin, Zhimei Liu, Ken Culver, Sumanta K. Pal, Jeffrey A. Scott & Nicholas J. Vogelzang. (2014) Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practices. Current Medical Research and Opinion 30:10, pages 2041-2050.
Read now

Articles from other publishers (7)

Nicola Longo, Marco Capece, Giuseppe Celentano, Roberto La Rocca, Gianluigi Califano, Claudia Collà Ruvolo, Carlo Buonerba, Fabio Esposito, Luigi Napolitano, Francesco Mangiapia, Ferdinando Fusco, Vincenzo Mirone & Massimiliano Creta. (2020) Clinical and Pathological Characteristics of Metastatic Renal Cell Carcinoma Patients Needing a Second-Line Therapy: A Systematic Review. Cancers 12:12, pages 3634.
Crossref
Thomas E Hutson, Xiaolong Jiao, Thomas Wilson, Laura Cisar & Elizabeth A MacLean. (2017) Axitinib in metastatic renal cell carcinoma: patient characteristics and treatment patterns in US community oncology centers. Future Oncology 13:15, pages 1323-1332.
Crossref
Hideaki Miyake, Ken-ichi Harada, Seiichiro Ozono & Masato Fujisawa. (2017) Assessment of Efficacy, Safety, and Quality of Life of 124 Patients Treated With Axitinib as Second-Line Therapy for Metastatic Renal-Cell Carcinoma: Experience in Real-World Clinical Practice in Japan. Clinical Genitourinary Cancer 15:1, pages 122-128.
Crossref
Elizabeth MacLean, Laura Cisar, Kimberly Mehle, Daria Eremina & Jane M. Quigley. (2016) Real-World Axitinib Use in the United States: A Retrospective Study Using Linked Datasets. Journal of Managed Care & Specialty Pharmacy 22:6, pages 723-732u.
Crossref
Shiven B. Patel, David D. Stenehjem, David M. Gill, Srinivas K. Tantravahi, Archana M. Agarwal, JoAnne Hsu, Winston Vuong, Sumanta K. Pal & Neeraj Agarwal. (2016) Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic Therapies. Clinical Genitourinary Cancer 14:2, pages 153-159.
Crossref
Sumanta K. Pal, James E. Signorovitch, William M. Reichmann, Nanxin Li, Valerie Koo, Zhimei Liu, Jose Ricardo Perez & Nicholas J. Vogelzang. (2016) Real-World Effectiveness of Everolimus Subsequent to Different First Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Synthesis of Retrospective Chart Reviews. Clinical Genitourinary Cancer 14:2, pages 160-167.e3.
Crossref
Anna M Czarnecka, Anna Kornakiewicz, Fei Lian & Cezary Szczylik. (2015) Future perspectives for mTOR inhibitors in renal cell cancer treatment. Future Oncology 11:5, pages 801-817.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.